首页|Evidence for the effectiveness of immunologic therapies in women with subfertility and/or undergoing assisted reproduction
Evidence for the effectiveness of immunologic therapies in women with subfertility and/or undergoing assisted reproduction
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
? 2022Implantation is a critical step in the establishment of a successful pregnancy, depending on a complex immune-endocrine dialogue between the developing embryo and maternal endometrium. Research suggests that altered immunity in the maternal decidua results in implantation impairment and failure. Immunomodulatory drugs have, thus, been widely used in assisted conception to aid embryo implantation, despite an absence of consensus on their effectiveness and safety. We conducted a systematic review and meta-analysis of interventional studies investigating the use of immunomodulators in women undergoing assisted reproduction. Evidence was uncertain of an effect for most of the included interventions, owing to heterogeneous findings and a paucity of high-quality studies. For certain patient subgroups, however, the use of specific immunomodulatory therapies may offer some benefit. There is a need for further large randomized controlled trials to corroborate these findings.
Immunomodulatory drugsimplantationinfertility
Melo P.、Thornton T.、Coomarasamy A.、Granne I.
展开 >
Tommy's National Centre for Miscarriage Research Institute of Metabolism and Systems Research
Jersey General Hospital St Helier
Nuffield Department of Women's and Reproductive Health University of Oxford
NSTL
Elsevier
